The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin. Biolinq says its ...
The Brighterside of News on MSN
Real-time glucose and heart monitoring in a smart wearable device
A new kind of wearable wristband could reshape how people with diabetes understand and manage their health. In addition to checking blood sugar, this wearable checks a series of important indicators ...
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.
Arecor Therapeutics announced today that it signed a co-development with Sequel Med Tech to pair their diabetes offerings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback